Peer-reviewed publications resulting from collaborative research projects.

  1. Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma.
  2. A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response.
  3. Development and validation of a plasma-based melanoma biomarker suitable for clinical use.
  4. Gene expression profiling during intensive cardiovascular lifestyle modification: Relationships with vascular function and weight loss.
  5. Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification.
  6. Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use.
  7. Gene expression differences in adipose tissue associated with breast tumorigenesis.
  8. Intensive cardiovascular risk reduction induces sustainable changes in expression of genes and pathways important to vascular function.
  9. BreastPRS is a gene expression assay that stratifies intermediate-risk Oncotype DX patients into high- or low-risk for disease recurrence.
  10. Recreational Music-Making alters gene expression pathways in patients with coronary heart disease.
  11. Effect of ASCO/CAP guidelines for determining ER status on molecular subtype.
  12. Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer.
  13. Design and multiseries validation of a web-based gene expression assay for predicting breast cancer recurrence and patient survival.
  14. Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.
  15. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
  16. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
  17. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
  18. Empirical array quality weights in the analysis of microarray data.
  19. Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus.
  20. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
  21. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.
  22. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
  23. Options available–from start to finish–for obtaining data from DNA microarrays II.